The Patent Finder

Andrx Corporation

Also on record
Records under this name other than patents Andrx Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Andrx Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,866,866Controlled release metformin compositions
Term ended
Term ended Apr 14, 2021 · USPTO record
Term endedTerm ended Apr 14, 2021USPTO record
US 6,790,459Methods for treating diabetes via administration of controlled release metformin
Term ended
Term ended Mar 17, 2021 · USPTO record
Term endedTerm ended Mar 17, 2021USPTO record
US 6,099,862Oral dosage form for the controlled release of a biguanide and sulfonylurea
Term ended
Term ended Aug 31, 2018 · USPTO record
Term endedTerm ended Aug 31, 2018USPTO record
US 6,720,003Serotonin reuptake inhibitor formulations
Formerly held
Lapsed on the fee record
Ended Apr 13, 2016 · USPTO record
Lapsed on the fee recordEnded Apr 13, 2016USPTO record
US 6,683,112Gabapentin prodrugs and formulations
Formerly held
Lapsed on the fee record
Ended Jan 27, 2016 · USPTO record
Lapsed on the fee recordEnded Jan 27, 2016USPTO record
US 6,610,326Divalproex sodium tablets
Lapsed on the fee record
Ended Aug 26, 2015 · USPTO record
Lapsed on the fee recordEnded Aug 26, 2015USPTO record
US 6,544,556Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
Lapsed on the fee record
Ended Apr 8, 2015 · USPTO record
Lapsed on the fee recordEnded Apr 8, 2015USPTO record
US 7,713,550Controlled release sodium valproate formulation
Lapsed on the fee record
Ended May 11, 2014 · USPTO record
Lapsed on the fee recordEnded May 11, 2014USPTO record
US 7,029,701Composition for the treatment and prevention of ischemic events
Formerly held
Lapsed on the fee record
Ended Apr 18, 2014 · USPTO record
Lapsed on the fee recordEnded Apr 18, 2014USPTO record
US 7,022,342Controlled release oral dosage form of beta-adrenergic blocking agents
Formerly held
Lapsed on the fee record
Ended Apr 4, 2010 · USPTO record
Lapsed on the fee recordEnded Apr 4, 2010USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited